SlideShare a Scribd company logo
1 of 8
Our scientists work in partnership with customers to provide sensitive, stable,
reproducible conjugates using our long-established proven processes
Gold conjugates
Anti-biotin
conjugates
Anti-human
conjugates
Anti-species
conjugates
Assay
Independent
Control Lines
Gold platinum
and latex Ab
conjugates Oligo Gold
conjugatesCustom
conjugation
A reliable assay depends on a high quality
reproducible gold conjugates – put an end to
the uncertainty of supply
 Quality - unique release QC requirements to
ensure every batch we deliver meets your
spec
 Specificity, sensitivity, reproducibility time
after time - stable, reproducible material
delivering consistent results
 Scaleable Bulk Production – from small
scale feasibility to continuous supply of your
optimised conjugate in bulk (up to 24L per
batch OD10)
 Proven - 25 years experience, results are fast
and your conjugate is optimised
“Our scientists perform over
500 conjugations every
year, for a variety of different
and often totally unique
applications”
Reliable supply
Designed to meet your individual needs
 Choose your target protein
(antibody/protein)
 Identify target sensitivity
 Identify Particle size
 Concentration of final conjugate
 Provide 3-5mg of protein for
conjugation and QC materials
 Initial 10ml of final optimised
product – (enough for 1000
prototype lateral flow test strips*)
 Excess reagents banked for future
production
 Full laboratory report on
performance customised to your
requirements
BBI OutputsCustomer Inputs
*using a 1:5 dilution of OD10 conjugate per strip
Outsource to the best in the business
Our services
 Sourcing your required antibody or protein
 Antibody screening
 Particle analysis
 Selection of appropriate final vehicle buffer for the conjugate
 Advice on the optimum nanoparticle and size to use for your application
 Conjugation of your antibody or protein to a nanoparticle and size of your choice
 Optimisation of sensitivity, and potential stability
Outsource to the best in the business
 Batch sizes up to 24L at OD10
 Custom OD preparation (not limited to OD10)
 Long term stability analysis (on request)
 QC test development
 Comprehensive lab report on conjugate performance
Our services
Off the shelf gold conjugates product list
*Trial products
Sensitive, stable, reproducible conjugates using our proven processes
Anti-Biotin Conjugates Disease State Conjugates Anti-Human Conjugates
 Streptavidin  Anti-HbsAg  Goat anti Human IgG
 Monoclonal anti biotin  Anti-CRP*  Protein A
 Goat anti biotin  Dengue*  Goat anti Human IgG Fc fragment
Control lines & Anti-species Other Conjugates  Goat anti Human IgM Fc5μ
fragment
 Chicken IgY  BSA conjugate  Goat anti Human IgA
 Goat anti-rabbit IgG  Anti-6 his tag conjugate*  Protein L*
 Mouse IgG Fertility Conjugates  Protein G*
 Goat anti-mouse
 Goat anti-mouse IgM
 Anti-beta hCG
 Anti-LH*
“Did you know our anti-
species conjugates can be
used for more than control
lines? Ask us how”
The Challenge
 A US company developed a lateral flow test using third party gold. The volumes
purchased were small - 100mls.
 The development was successful, optimisation of the test was completed with
transfer to manufacturing
 A larger batch of gold was ordered for the validation - the tests failed
 The test was sent back to R+D for troubleshooting, after a month it was proven
that the conjugate used in validation was not performing the same as the smaller
batches …
Solving the issues of a
non-scalable conjugate
Success Story
The Solution
 BBI carried out a custom conjugation and optimised the conjugate to meet the
final R&D test conditions
 Three large scale batches of conjugate produced for customer validation
 Each validation exercise was successful and the product moved into production
 The customer put the test through regulatory submission and completed the
clinical trials without further delay
Solving the issues of a
non-scalable conjugate
Success Story

More Related Content

What's hot

Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...MilliporeSigma
 
Kurtz biomanufacturing
Kurtz biomanufacturingKurtz biomanufacturing
Kurtz biomanufacturingbio-link
 
Covering a Spectrum of New Product Development Technologies - From Cells to C...
Covering a Spectrum of New Product Development Technologies - From Cells to C...Covering a Spectrum of New Product Development Technologies - From Cells to C...
Covering a Spectrum of New Product Development Technologies - From Cells to C...KBI Biopharma
 
HJB CDMO Introduction (2019)
HJB CDMO Introduction (2019)HJB CDMO Introduction (2019)
HJB CDMO Introduction (2019)XiaomingJerryYang
 
Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...
Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...
Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...MilliporeSigma
 
Accelerating COVID-19 Therapies: How a streamlined biosafety strategy can get...
Accelerating COVID-19 Therapies: How a streamlined biosafety strategy can get...Accelerating COVID-19 Therapies: How a streamlined biosafety strategy can get...
Accelerating COVID-19 Therapies: How a streamlined biosafety strategy can get...Merck Life Sciences
 
Accelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell LinesAccelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell LinesMerck Life Sciences
 
Webinar: Benefits of Monodisperse Activated PEGs in ADC Development
Webinar: Benefits of Monodisperse Activated PEGs in ADC DevelopmentWebinar: Benefits of Monodisperse Activated PEGs in ADC Development
Webinar: Benefits of Monodisperse Activated PEGs in ADC DevelopmentMilliporeSigma
 
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...MilliporeSigma
 
Promises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Promises and Challenges of Manufacturing and Testing Viral Producer Cell LinesPromises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Promises and Challenges of Manufacturing and Testing Viral Producer Cell LinesMerck Life Sciences
 
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationEU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationMilliporeSigma
 
Webinar: Evaluating Viral Clearance for Continuous Processes
Webinar: Evaluating Viral Clearance for Continuous ProcessesWebinar: Evaluating Viral Clearance for Continuous Processes
Webinar: Evaluating Viral Clearance for Continuous ProcessesMilliporeSigma
 
From preclinical to commercial: The evolution of ADC manufacturing expertise ...
From preclinical to commercial: The evolution of ADC manufacturing expertise ...From preclinical to commercial: The evolution of ADC manufacturing expertise ...
From preclinical to commercial: The evolution of ADC manufacturing expertise ...MilliporeSigma
 
Process development guidance for AAV and lentivirus manufacturing based on co...
Process development guidance for AAV and lentivirus manufacturing based on co...Process development guidance for AAV and lentivirus manufacturing based on co...
Process development guidance for AAV and lentivirus manufacturing based on co...MilliporeSigma
 
Get Proactive With Your Stability Program
Get Proactive With Your Stability ProgramGet Proactive With Your Stability Program
Get Proactive With Your Stability ProgramMerck Life Sciences
 
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...Merck Life Sciences
 
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial TestingBiopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial TestingKBI Biopharma
 
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyProcess Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyMerck Life Sciences
 

What's hot (20)

Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
 
Kurtz biomanufacturing
Kurtz biomanufacturingKurtz biomanufacturing
Kurtz biomanufacturing
 
Covering a Spectrum of New Product Development Technologies - From Cells to C...
Covering a Spectrum of New Product Development Technologies - From Cells to C...Covering a Spectrum of New Product Development Technologies - From Cells to C...
Covering a Spectrum of New Product Development Technologies - From Cells to C...
 
HJB CDMO Introduction (2019)
HJB CDMO Introduction (2019)HJB CDMO Introduction (2019)
HJB CDMO Introduction (2019)
 
Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...
Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...
Webinar: How Biosafety Testing will Evolve to Meet the Needs of Biologics Man...
 
Gene Therapy Services
Gene Therapy ServicesGene Therapy Services
Gene Therapy Services
 
Accelerating COVID-19 Therapies: How a streamlined biosafety strategy can get...
Accelerating COVID-19 Therapies: How a streamlined biosafety strategy can get...Accelerating COVID-19 Therapies: How a streamlined biosafety strategy can get...
Accelerating COVID-19 Therapies: How a streamlined biosafety strategy can get...
 
Accelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell LinesAccelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell Lines
 
Webinar: Benefits of Monodisperse Activated PEGs in ADC Development
Webinar: Benefits of Monodisperse Activated PEGs in ADC DevelopmentWebinar: Benefits of Monodisperse Activated PEGs in ADC Development
Webinar: Benefits of Monodisperse Activated PEGs in ADC Development
 
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
 
Promises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Promises and Challenges of Manufacturing and Testing Viral Producer Cell LinesPromises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
Promises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
 
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationEU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
 
Webinar: Evaluating Viral Clearance for Continuous Processes
Webinar: Evaluating Viral Clearance for Continuous ProcessesWebinar: Evaluating Viral Clearance for Continuous Processes
Webinar: Evaluating Viral Clearance for Continuous Processes
 
Ils Information
Ils InformationIls Information
Ils Information
 
From preclinical to commercial: The evolution of ADC manufacturing expertise ...
From preclinical to commercial: The evolution of ADC manufacturing expertise ...From preclinical to commercial: The evolution of ADC manufacturing expertise ...
From preclinical to commercial: The evolution of ADC manufacturing expertise ...
 
Process development guidance for AAV and lentivirus manufacturing based on co...
Process development guidance for AAV and lentivirus manufacturing based on co...Process development guidance for AAV and lentivirus manufacturing based on co...
Process development guidance for AAV and lentivirus manufacturing based on co...
 
Get Proactive With Your Stability Program
Get Proactive With Your Stability ProgramGet Proactive With Your Stability Program
Get Proactive With Your Stability Program
 
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
 
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial TestingBiopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
 
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyProcess Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
 

Similar to BBI Solutions - Conjugates

Linkedin Gen Script
Linkedin Gen ScriptLinkedin Gen Script
Linkedin Gen Scripthowardhuang
 
Linkedin Gen Script
Linkedin Gen ScriptLinkedin Gen Script
Linkedin Gen Scripthowardhuang
 
Life Sciences Products Services at Biomatik
Life Sciences Products Services at BiomatikLife Sciences Products Services at Biomatik
Life Sciences Products Services at BiomatikBiomatik
 
Adherent Lentivirus Suspension Production & Manufacturing.pptx
Adherent Lentivirus Suspension Production & Manufacturing.pptxAdherent Lentivirus Suspension Production & Manufacturing.pptx
Adherent Lentivirus Suspension Production & Manufacturing.pptxGenScript ProBio
 
Genscript overview 030110[1]
Genscript overview 030110[1]Genscript overview 030110[1]
Genscript overview 030110[1]nicole_niu
 
One-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioOne-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioGenScript ProBio
 
Customer Review For NCKX3 Polyclonal Antibody (STJ94358)
Customer Review For NCKX3 Polyclonal Antibody (STJ94358)Customer Review For NCKX3 Polyclonal Antibody (STJ94358)
Customer Review For NCKX3 Polyclonal Antibody (STJ94358)St John's Laboratory Ltd
 
Customer Review For mGluR8 Polyclonal Antibody (STJ94114)
Customer Review For mGluR8 Polyclonal Antibody (STJ94114)Customer Review For mGluR8 Polyclonal Antibody (STJ94114)
Customer Review For mGluR8 Polyclonal Antibody (STJ94114)St John's Laboratory Ltd
 
High throughput antibody production
High throughput antibody productionHigh throughput antibody production
High throughput antibody productionCandy Swift
 
High throughput antibody production
High throughput antibody productionHigh throughput antibody production
High throughput antibody productionCandy Swift
 
Solutions to life sciences
Solutions to life sciencesSolutions to life sciences
Solutions to life sciencesEUROPAGES
 
Ko services brochure-online-hi-jan2021b
Ko services brochure-online-hi-jan2021bKo services brochure-online-hi-jan2021b
Ko services brochure-online-hi-jan2021bSteve Brough
 
Customer Review For NCKX4 Polyclonal Antibody (STJ94359)
Customer Review For NCKX4 Polyclonal Antibody (STJ94359)Customer Review For NCKX4 Polyclonal Antibody (STJ94359)
Customer Review For NCKX4 Polyclonal Antibody (STJ94359)St John's Laboratory Ltd
 
Group 3 MA60 grifols marketing plan (slides)
Group 3 MA60 grifols marketing plan (slides)Group 3 MA60 grifols marketing plan (slides)
Group 3 MA60 grifols marketing plan (slides)John Acener Padua
 
Solis_BioDyne_Catalogue_2015
Solis_BioDyne_Catalogue_2015Solis_BioDyne_Catalogue_2015
Solis_BioDyne_Catalogue_2015Daren Clare
 
Customer Review For ELMOD2 Polyclonal Antibody (STJ27186)
Customer Review For ELMOD2 Polyclonal Antibody (STJ27186)Customer Review For ELMOD2 Polyclonal Antibody (STJ27186)
Customer Review For ELMOD2 Polyclonal Antibody (STJ27186)St John's Laboratory Ltd
 

Similar to BBI Solutions - Conjugates (20)

Linkedin Gen Script
Linkedin Gen ScriptLinkedin Gen Script
Linkedin Gen Script
 
Linkedin Gen Script
Linkedin Gen ScriptLinkedin Gen Script
Linkedin Gen Script
 
Life Sciences Products Services at Biomatik
Life Sciences Products Services at BiomatikLife Sciences Products Services at Biomatik
Life Sciences Products Services at Biomatik
 
Adherent Lentivirus Suspension Production & Manufacturing.pptx
Adherent Lentivirus Suspension Production & Manufacturing.pptxAdherent Lentivirus Suspension Production & Manufacturing.pptx
Adherent Lentivirus Suspension Production & Manufacturing.pptx
 
Genscript overview 030110[1]
Genscript overview 030110[1]Genscript overview 030110[1]
Genscript overview 030110[1]
 
Genscript Overview
Genscript OverviewGenscript Overview
Genscript Overview
 
Marketing Material - General
Marketing Material - GeneralMarketing Material - General
Marketing Material - General
 
DCN Company Profile 2015
DCN Company Profile 2015DCN Company Profile 2015
DCN Company Profile 2015
 
One-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBioOne-Stop Antibody Drug Discovery Services from GenScript ProBio
One-Stop Antibody Drug Discovery Services from GenScript ProBio
 
Customer Review For NCKX3 Polyclonal Antibody (STJ94358)
Customer Review For NCKX3 Polyclonal Antibody (STJ94358)Customer Review For NCKX3 Polyclonal Antibody (STJ94358)
Customer Review For NCKX3 Polyclonal Antibody (STJ94358)
 
Customer Review For mGluR8 Polyclonal Antibody (STJ94114)
Customer Review For mGluR8 Polyclonal Antibody (STJ94114)Customer Review For mGluR8 Polyclonal Antibody (STJ94114)
Customer Review For mGluR8 Polyclonal Antibody (STJ94114)
 
High throughput antibody production
High throughput antibody productionHigh throughput antibody production
High throughput antibody production
 
High throughput antibody production
High throughput antibody productionHigh throughput antibody production
High throughput antibody production
 
GMO Analysis
GMO AnalysisGMO Analysis
GMO Analysis
 
Solutions to life sciences
Solutions to life sciencesSolutions to life sciences
Solutions to life sciences
 
Ko services brochure-online-hi-jan2021b
Ko services brochure-online-hi-jan2021bKo services brochure-online-hi-jan2021b
Ko services brochure-online-hi-jan2021b
 
Customer Review For NCKX4 Polyclonal Antibody (STJ94359)
Customer Review For NCKX4 Polyclonal Antibody (STJ94359)Customer Review For NCKX4 Polyclonal Antibody (STJ94359)
Customer Review For NCKX4 Polyclonal Antibody (STJ94359)
 
Group 3 MA60 grifols marketing plan (slides)
Group 3 MA60 grifols marketing plan (slides)Group 3 MA60 grifols marketing plan (slides)
Group 3 MA60 grifols marketing plan (slides)
 
Solis_BioDyne_Catalogue_2015
Solis_BioDyne_Catalogue_2015Solis_BioDyne_Catalogue_2015
Solis_BioDyne_Catalogue_2015
 
Customer Review For ELMOD2 Polyclonal Antibody (STJ27186)
Customer Review For ELMOD2 Polyclonal Antibody (STJ27186)Customer Review For ELMOD2 Polyclonal Antibody (STJ27186)
Customer Review For ELMOD2 Polyclonal Antibody (STJ27186)
 

More from BBISolutions

Clinical Samples & Disease State Plasma Newsflash October 2016
Clinical Samples & Disease State Plasma Newsflash October 2016Clinical Samples & Disease State Plasma Newsflash October 2016
Clinical Samples & Disease State Plasma Newsflash October 2016BBISolutions
 
Clinical Samples & Disease State Plasma Newsflash October 2016 final
Clinical Samples & Disease State Plasma Newsflash October 2016 finalClinical Samples & Disease State Plasma Newsflash October 2016 final
Clinical Samples & Disease State Plasma Newsflash October 2016 finalBBISolutions
 
Disease State Plasma
Disease State PlasmaDisease State Plasma
Disease State PlasmaBBISolutions
 
BBI Solutions - Antibodies
BBI Solutions - AntibodiesBBI Solutions - Antibodies
BBI Solutions - AntibodiesBBISolutions
 
September 2015 - Antibodies Newsflash - BBI Solutions
September 2015 - Antibodies Newsflash - BBI SolutionsSeptember 2015 - Antibodies Newsflash - BBI Solutions
September 2015 - Antibodies Newsflash - BBI SolutionsBBISolutions
 
Antibodies - Key Marker Performance - July 2015
Antibodies - Key Marker Performance - July 2015Antibodies - Key Marker Performance - July 2015
Antibodies - Key Marker Performance - July 2015BBISolutions
 
BBI Solutions - Human Proteins
BBI Solutions - Human ProteinsBBI Solutions - Human Proteins
BBI Solutions - Human ProteinsBBISolutions
 
May 2015 Antibodies Newsflash - BBI Solutions
May 2015 Antibodies Newsflash - BBI SolutionsMay 2015 Antibodies Newsflash - BBI Solutions
May 2015 Antibodies Newsflash - BBI SolutionsBBISolutions
 
April 2015 - Disease State Plasma Newsflash - BBI Solutions
April 2015 - Disease State Plasma Newsflash - BBI SolutionsApril 2015 - Disease State Plasma Newsflash - BBI Solutions
April 2015 - Disease State Plasma Newsflash - BBI SolutionsBBISolutions
 
BBI Solutions - Nanoparticles
BBI Solutions - NanoparticlesBBI Solutions - Nanoparticles
BBI Solutions - NanoparticlesBBISolutions
 
January 2015 antibodies newsflash
January 2015   antibodies newsflashJanuary 2015   antibodies newsflash
January 2015 antibodies newsflashBBISolutions
 
January 2015 - Antibodies Newsflash
January 2015 - Antibodies NewsflashJanuary 2015 - Antibodies Newsflash
January 2015 - Antibodies NewsflashBBISolutions
 
Antibodies Newsflash - September 2014 - BBI Solutions
Antibodies Newsflash - September 2014 - BBI SolutionsAntibodies Newsflash - September 2014 - BBI Solutions
Antibodies Newsflash - September 2014 - BBI SolutionsBBISolutions
 
Disease State Plasma Newsflash - August 2014 - BBI Solutions
Disease State Plasma Newsflash - August 2014 - BBI SolutionsDisease State Plasma Newsflash - August 2014 - BBI Solutions
Disease State Plasma Newsflash - August 2014 - BBI SolutionsBBISolutions
 
April 2014 - Antibodies Newsflash - BBI Solutions
April 2014 - Antibodies Newsflash - BBI SolutionsApril 2014 - Antibodies Newsflash - BBI Solutions
April 2014 - Antibodies Newsflash - BBI SolutionsBBISolutions
 
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI SolutionsDisease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI SolutionsBBISolutions
 

More from BBISolutions (16)

Clinical Samples & Disease State Plasma Newsflash October 2016
Clinical Samples & Disease State Plasma Newsflash October 2016Clinical Samples & Disease State Plasma Newsflash October 2016
Clinical Samples & Disease State Plasma Newsflash October 2016
 
Clinical Samples & Disease State Plasma Newsflash October 2016 final
Clinical Samples & Disease State Plasma Newsflash October 2016 finalClinical Samples & Disease State Plasma Newsflash October 2016 final
Clinical Samples & Disease State Plasma Newsflash October 2016 final
 
Disease State Plasma
Disease State PlasmaDisease State Plasma
Disease State Plasma
 
BBI Solutions - Antibodies
BBI Solutions - AntibodiesBBI Solutions - Antibodies
BBI Solutions - Antibodies
 
September 2015 - Antibodies Newsflash - BBI Solutions
September 2015 - Antibodies Newsflash - BBI SolutionsSeptember 2015 - Antibodies Newsflash - BBI Solutions
September 2015 - Antibodies Newsflash - BBI Solutions
 
Antibodies - Key Marker Performance - July 2015
Antibodies - Key Marker Performance - July 2015Antibodies - Key Marker Performance - July 2015
Antibodies - Key Marker Performance - July 2015
 
BBI Solutions - Human Proteins
BBI Solutions - Human ProteinsBBI Solutions - Human Proteins
BBI Solutions - Human Proteins
 
May 2015 Antibodies Newsflash - BBI Solutions
May 2015 Antibodies Newsflash - BBI SolutionsMay 2015 Antibodies Newsflash - BBI Solutions
May 2015 Antibodies Newsflash - BBI Solutions
 
April 2015 - Disease State Plasma Newsflash - BBI Solutions
April 2015 - Disease State Plasma Newsflash - BBI SolutionsApril 2015 - Disease State Plasma Newsflash - BBI Solutions
April 2015 - Disease State Plasma Newsflash - BBI Solutions
 
BBI Solutions - Nanoparticles
BBI Solutions - NanoparticlesBBI Solutions - Nanoparticles
BBI Solutions - Nanoparticles
 
January 2015 antibodies newsflash
January 2015   antibodies newsflashJanuary 2015   antibodies newsflash
January 2015 antibodies newsflash
 
January 2015 - Antibodies Newsflash
January 2015 - Antibodies NewsflashJanuary 2015 - Antibodies Newsflash
January 2015 - Antibodies Newsflash
 
Antibodies Newsflash - September 2014 - BBI Solutions
Antibodies Newsflash - September 2014 - BBI SolutionsAntibodies Newsflash - September 2014 - BBI Solutions
Antibodies Newsflash - September 2014 - BBI Solutions
 
Disease State Plasma Newsflash - August 2014 - BBI Solutions
Disease State Plasma Newsflash - August 2014 - BBI SolutionsDisease State Plasma Newsflash - August 2014 - BBI Solutions
Disease State Plasma Newsflash - August 2014 - BBI Solutions
 
April 2014 - Antibodies Newsflash - BBI Solutions
April 2014 - Antibodies Newsflash - BBI SolutionsApril 2014 - Antibodies Newsflash - BBI Solutions
April 2014 - Antibodies Newsflash - BBI Solutions
 
Disease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI SolutionsDisease State Plasma Newsflash - January 2014 - BBI Solutions
Disease State Plasma Newsflash - January 2014 - BBI Solutions
 

Recently uploaded

Boyles law module in the grade 10 science
Boyles law module in the grade 10 scienceBoyles law module in the grade 10 science
Boyles law module in the grade 10 sciencefloriejanemacaya1
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxgindu3009
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...anilsa9823
 
Nanoparticles synthesis and characterization​ ​
Nanoparticles synthesis and characterization​  ​Nanoparticles synthesis and characterization​  ​
Nanoparticles synthesis and characterization​ ​kaibalyasahoo82800
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsAArockiyaNisha
 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfSumit Kumar yadav
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhousejana861314
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...Sérgio Sacani
 
Caco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionCaco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionPriyansha Singh
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bSérgio Sacani
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisDiwakar Mishra
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTSérgio Sacani
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxAArockiyaNisha
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Sérgio Sacani
 

Recently uploaded (20)

Boyles law module in the grade 10 science
Boyles law module in the grade 10 scienceBoyles law module in the grade 10 science
Boyles law module in the grade 10 science
 
Engler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomyEngler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomy
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptx
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
 
The Philosophy of Science
The Philosophy of ScienceThe Philosophy of Science
The Philosophy of Science
 
Nanoparticles synthesis and characterization​ ​
Nanoparticles synthesis and characterization​  ​Nanoparticles synthesis and characterization​  ​
Nanoparticles synthesis and characterization​ ​
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdf
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhouse
 
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
 
Caco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionCaco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorption
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOST
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
 

BBI Solutions - Conjugates

  • 1. Our scientists work in partnership with customers to provide sensitive, stable, reproducible conjugates using our long-established proven processes Gold conjugates Anti-biotin conjugates Anti-human conjugates Anti-species conjugates Assay Independent Control Lines Gold platinum and latex Ab conjugates Oligo Gold conjugatesCustom conjugation
  • 2. A reliable assay depends on a high quality reproducible gold conjugates – put an end to the uncertainty of supply  Quality - unique release QC requirements to ensure every batch we deliver meets your spec  Specificity, sensitivity, reproducibility time after time - stable, reproducible material delivering consistent results  Scaleable Bulk Production – from small scale feasibility to continuous supply of your optimised conjugate in bulk (up to 24L per batch OD10)  Proven - 25 years experience, results are fast and your conjugate is optimised “Our scientists perform over 500 conjugations every year, for a variety of different and often totally unique applications” Reliable supply
  • 3. Designed to meet your individual needs  Choose your target protein (antibody/protein)  Identify target sensitivity  Identify Particle size  Concentration of final conjugate  Provide 3-5mg of protein for conjugation and QC materials  Initial 10ml of final optimised product – (enough for 1000 prototype lateral flow test strips*)  Excess reagents banked for future production  Full laboratory report on performance customised to your requirements BBI OutputsCustomer Inputs *using a 1:5 dilution of OD10 conjugate per strip
  • 4. Outsource to the best in the business Our services  Sourcing your required antibody or protein  Antibody screening  Particle analysis  Selection of appropriate final vehicle buffer for the conjugate  Advice on the optimum nanoparticle and size to use for your application  Conjugation of your antibody or protein to a nanoparticle and size of your choice  Optimisation of sensitivity, and potential stability
  • 5. Outsource to the best in the business  Batch sizes up to 24L at OD10  Custom OD preparation (not limited to OD10)  Long term stability analysis (on request)  QC test development  Comprehensive lab report on conjugate performance Our services
  • 6. Off the shelf gold conjugates product list *Trial products Sensitive, stable, reproducible conjugates using our proven processes Anti-Biotin Conjugates Disease State Conjugates Anti-Human Conjugates  Streptavidin  Anti-HbsAg  Goat anti Human IgG  Monoclonal anti biotin  Anti-CRP*  Protein A  Goat anti biotin  Dengue*  Goat anti Human IgG Fc fragment Control lines & Anti-species Other Conjugates  Goat anti Human IgM Fc5μ fragment  Chicken IgY  BSA conjugate  Goat anti Human IgA  Goat anti-rabbit IgG  Anti-6 his tag conjugate*  Protein L*  Mouse IgG Fertility Conjugates  Protein G*  Goat anti-mouse  Goat anti-mouse IgM  Anti-beta hCG  Anti-LH* “Did you know our anti- species conjugates can be used for more than control lines? Ask us how”
  • 7. The Challenge  A US company developed a lateral flow test using third party gold. The volumes purchased were small - 100mls.  The development was successful, optimisation of the test was completed with transfer to manufacturing  A larger batch of gold was ordered for the validation - the tests failed  The test was sent back to R+D for troubleshooting, after a month it was proven that the conjugate used in validation was not performing the same as the smaller batches … Solving the issues of a non-scalable conjugate Success Story
  • 8. The Solution  BBI carried out a custom conjugation and optimised the conjugate to meet the final R&D test conditions  Three large scale batches of conjugate produced for customer validation  Each validation exercise was successful and the product moved into production  The customer put the test through regulatory submission and completed the clinical trials without further delay Solving the issues of a non-scalable conjugate Success Story

Editor's Notes

  1. Key point: Communicate that our custom conjugation is a true partnership. Customers can talk with scientists working on their product before, during and after to make sure it is optimised for their assay.
  2. Point 1: we have experience with polyclonal and monoclonal antibodies, Fab, F(ab)2, ScFv, proteins, peptides, oligonucleotides and thiol-linked biomolecules Point 3: we can analyse the customer’s existing materials and advise on optimal particle size
  3. Example where anti-species can be used for more than just control line (Nikki Robinson):   BAGAR40 -  Goat anti Rabbit IgG:40nm. This is whole molecule so detects both heavy and light chains of rabbit IgG.   You can use BAGAR40 as a control line. Just stripe down rabbit IgG as the control line antibody and the BAGAR40 will detect it. Works well as independent control line with monoclonal detector conjugates such as monoclonal anti CRP:40nm.   BAGAR40 can also be used as a detector antibody. You take the BAGAR40 and simply mix it with the rabbit antibody you want to label. Lets say the rabbit antibody is rabbit anti Plague. You then have a nice complex of BAGAR40 with rabbit anti plague. Now you can use this to detect plague in a lateral flow test.   This will work even better if you use TR.GARFC, or for monoclonals TR.GAMFC – what I mean here is that the GARFC is goat anti rabbit IgG Fc fragment specific, so it binds the FC portion of the rabbit anti plague, so it even orientates the rabbit anti plague in the right direction. For GAMFC it means goat anti mouse IgG Fc fragment specific so it would pick up mouse anti plague and orientate that in the right direction. When I say right direction I mean that the Fab region of  the antibody is protruding nicely to detect plague!
  4. Point 1: - we have experience with polyclonal and monoclonal antibodies, Fab, F(ab)2, ScFv, proteins, peptides, oligonucleotides and thiol-linked biomolecules
  5. Point 1: - we have experience with polyclonal and monoclonal antibodies, Fab, F(ab)2, ScFv, proteins, peptides, oligonucleotides and thiol-linked biomolecules